Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
journalStr:"WHO International Clinical Trials Registry Platform"
format_facet:"Elektronische Ressource"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (34)
1
A trial to test the safety and efficacy of a new drug (human immune cells against COVID-19, administered intravenously) for patients with COVID-19 in need of treatment or at risk for severe COVID-19 : A Phase I / randomized Phase II trial to analyse safety and efficacy of human SARS-CoV 2 specific T lymphocyte transfer in patients with COVID-19 in need of treatment or at risk of severe COVID-19 - ACT-COVID19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
2
A trial to test the safety and efficacy of a new drug (human immune cells against COVID-19, administered intravenously) for patients with COVID-19 in need of treatment or at risk for severe COVID-19 : A Phase I / randomized Phase II trial to analyse safety and efficacy of human SARS-CoV 2 specific T lymphocyte transfer in patients with COVID-19 in need of treatment or at risk of severe COVID-19 - ACT-COVID19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
3
A multi-center phase Ib trial to assess the safety, tolerability and immunogenicity of the candidate vaccine MVA-SARS-2-ST in adults : A multi-center, phase Ib trial to assess the safety, tolerability and immunogenicity of the candidate vaccine MVA-SARS-2-ST in adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
A multi-center phase Ib trial to assess the safety, tolerability and immunogenicity of the candidate vaccine MVA-SARS-2-ST in adults : A multi-center, phase Ib trial to assess the safety, tolerability and immunogenicity of the candidate vaccine MVA-SARS-2-ST in adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
A study to evaluate safety, reactogenicity and immunogenicity of Ad26COVS1 in adults : A Randomized, Double-blind, Placebo-controlled Phase 1/2a Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26COVS1 in Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Years and Older
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
A study to evaluate safety, reactogenicity and immunogenicity of Ad26COVS1 in adults : A Randomized, Double-blind, Placebo-controlled Phase 1/2a Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26COVS1 in Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Years and Older
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
An Open-Label, Single/Multiple Ascending Dose Study to Assess the Pharmacokinetics, Efficacy, Safety and Tolerability of Inhalation Delivery of Hydroxychloroquine Sulfate (HCQ) in Healthy Volunteers and patients with COVID-19 : An Open-Label, Single/Multiple Ascending Dose Study to Assess the Pharmacokinetics, Efficacy, Safety and Tolerability of Inhalation Delivery of Hydroxychloroquine Sulfate (HCQ) in Healthy Volunteers and patients with COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
An Open-Label, Single/Multiple Ascending Dose Study to Assess the Pharmacokinetics, Efficacy, Safety and Tolerability of Inhalation Delivery of Hydroxychloroquine Sulfate (HCQ) in Healthy Volunteers and patients with COVID-19 : An Open-Label, Single/Multiple Ascending Dose Study to Assess the Pharmacokinetics, Efficacy, Safety and Tolerability of Inhalation Delivery of Hydroxychloroquine Sulfate (HCQ) in Healthy Volunteers and patients with COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
A phase I study to evaluate safety and immunogenicity of recombinant protein candidate vaccine against SARS-CoV-2 in healthy volunteers. : A phase I/IIa study to evaluate safety and immunogenicity of recombinant protein RBD fusion dimer candidate vaccine against SARS-CoV-2 in adult healthy volunteers.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
A phase I study to evaluate safety and immunogenicity of recombinant protein candidate vaccine against SARS-CoV-2 in healthy volunteers. : A phase I/IIa study to evaluate safety and immunogenicity of recombinant protein RBD fusion dimer candidate vaccine against SARS-CoV-2 in adult healthy volunteers.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Filter aufheben
Thema: Phase: Phase 1
Medienart
34
Aufsätze
34
E-Artikel
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
34
610
Phase: Phase 1
Recruitment Status: Authorised-recruitment may ...
34
Study Type: Interventional
2
Medical Condition: Acute respiratory distress s...
2
Medical Condition: COVID-19 MedDRA version: 23....
2
Medical Condition: COVID-19 or protective effec...
2
Medical Condition: COVID-19 vaccine response in...
2
Medical Condition: Coronavirus-induced disease ...
2
Medical Condition: Evaluation of the inflammato...
2
Medical Condition: Healthy volunteers (Preventi...
2
Medical Condition: Healthy volunteers MedDRA ve...
2
Medical Condition: Healthy volunteers and patie...
2
Medical Condition: Moderate COVID-19 MedDRA ver...
2
Medical Condition: Patients hospitalised for CO...
2
Medical Condition: Patients who are tested posi...
2
Medical Condition: SARS-CoV-2 MedDRA version: 2...
2
Medical Condition: SARS-CoV-2 pneumonia MedDRA ...
2
Medical Condition: Severe COVID-19 pneumonia Me...
2
Medical Condition: This study is designed to ev...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
24
2021
10
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
34
Englisch
Haven't found what you're looking for?
Wird geladen...